Corporació Sanitària Parc Taulí
Sabadell, Barcelona, 08208, Spain
NCT Number: NCT02199132
Retrospective study of patients diagnosed with a nasopharyngeal carcinoma included in our data base care between June 1990 and September 2013.
Our hypothesis is:
Our series of patients with a history of nasopharyngeal carcinoma presents epidemiological, response rates to the different treatments and survival similar to those described in the literature
Looking for future studies?
Notify MeAll sexes
Observational
Sabadell, Barcelona, 08208, Spain
Retrospective study of 50 patients diagnosed with nasopharyngeal carcinoma. The following variables will be studied: age, sex, toxic habits , associated pathology, patient origin , first symptom , duration , histology, stage , second malignancies , recurrences , metastases , treatments performed , the response thereto and survival.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year after diagnostic
Describe our population diagnosed nasopharyngeal carcinoma and compared in epidemiology and therapeutic results with those in the literature
Corporacion Parc Tauli
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04528394
Carcinoma, Head and Neck Neoplasms
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03240835
Carcinoma, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT03848286
Carcinoma, Disease Attributes
Beijing, Beijing Municipality, China
View Trial DetailsNCT02633202
Carcinoma, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial Details